UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 20, 2023
Accession Number:
0001140361-23-012421
Submission Type:
POS AM
CIK:
0000748592
Company Name:
Eterna Therapeutics Inc.
File Number:
333-264585